Haemonetics

company based in Braintree, Massachusetts, USA

HAE NYSE ISIN US4050241003 SEC CIK 313143 LEI 549300ZEL6TXZS6F5F95
Follow Haemonetics Weekly email: filings, results

Financials

Reported figures only · latest: Q4 2026 USD · US GAAP
Revenue, last quarter $346.4M +4.8% vs same quarter last year
Net income −$117.4M −7.1% vs same quarter last year
EPS, diluted -
Operating cash flow $70.9M −39.1% vs same quarter last year
Revenue by quarter
$336.3M
$343.3M
$348.5M
$330.6M
$339M
$346.4M
Q3 24 Q4 24 Q3 25 Q4 25 Q3 26 Q4 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$500M$0$500M$1B$1.5BFY12FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearRevenueNet income
FY26$1.3B$97.3K
FY25$1.4B$167.7K
FY24$1.3B$117.6M
FY23$1.2B$115.4M
FY22$993.2M$43.4M
FY21$870.5M$79.5M
FY20$988.5M$76.5M
FY19$967.6M$55M
FY18$903.9M$45.6M
FY17$886.1M−$26.3M
FY16$908.8M−$55.6M
FY15$910.4M$16.9M
FY14$938.5M$35.1M
FY13$892M$38.8M
FY12$727.8M$66.9M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−20%0%20%40%60%FY12FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearGross marginOperating marginNet margin
FY2659%11.7%0%
FY2555%16.3%0%
FY2452.8%12.6%9%
FY2352.6%13.4%9.9%
FY2250.9%8.1%4.4%
FY2145.7%10.3%9.1%
FY2049%10.5%7.7%
FY1943.2%8.6%5.7%
FY1845.6%6.2%5%
FY1742.7%−2.2%−3%
FY1644.7%−4.8%−6.1%
FY1547.7%4.5%1.9%
FY1449.9%4.9%3.7%
FY1348%6.3%4.3%
FY1250.7%12.2%9.2%
Free cash flowOperating cash flow minus capital expenditure
$0$100M$200M$300MFY12FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearFree cash flow
FY26$260.4M
FY25$142.4M
FY24$143.6M
FY23$81.7M
FY22$75.8M
FY21$71.8M
FY20$109.5M
FY19$40.3M
FY18$145.6M
FY17$83.6M
FY16$19.5M
FY15$5M
FY14$65.9M
FY13$22.9M
FY12$62.1M
Returned to shareholdersDividends paid and shares bought back
$0$100M$200M$300MFY12FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearBuybacks
FY26$175M
FY25$225M
FY24$0
FY23$75M
FY22$0
FY21$0
FY20$175M
FY19$160M
FY18$100M
FY17$0
FY16$61M
FY15$39M
FY14$0
FY13$50M
FY12$50M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Haemonetics
  • Healthcare median
−100%−75%−50%−25%0%25%FY12FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearHaemoneticsHealthcare median
FY260%−11.1%
FY250%−30.6%
FY249%−47%
FY239.9%−58%
FY224.4%−80.4%
FY219.1%−71.9%
FY207.7%−62.2%
FY195.7%−46.3%
FY185%−49.6%
FY17−3%−45.9%
FY16−6.1%−36%
FY151.9%−38.4%
FY143.7%−35.5%
FY134.3%−37.1%
FY129.2%−29.1%